Emlyn Samuel

Cancer Research UK
Head of Policy Development

Emlyn leads the policy development team at Cancer Research UK. His team is responsible for developing the charity''''s position on areas of public policy on a range of issues. This includes the how Government can support a thriving research environment, how cancer services are run - to diagnose patients earlier and provide better access to treatment - and how charity laws should be reformed.

His previous roles include policy positions at the Wellcome Trust, The Academy of Medical Sciences, and a secondment to the Office for Life Sciences to support the development of the Life Sciences Industrial Strategy.

dont miss

Brexit: getting the best outcome for research and patients

This seminar will discuss Cancer Research UK’s policy work on Brexit, including evidence about the impact of UK-EU collaboration and what our priorities are for negotiations about the future relationship between the UK and EU.

EVEN MORE SEMINARS

  • Imran Liaquat MBChB BSc MedSci MRCS FRCS MEd: Speaking at the Oncology Convention

    Imran Liaquat MBChB BSc MedSci MRCS FRCS MEd
    NHS Lothian, Scotland

    Optimising Surgical Resection in Low Grade Glioma Patients

  • Laura Allington: Speaking at the Oncology Convention

    Laura Allington
    University College London Hospitals NHS Foundation Trust

    Operational challenges of planning a new NHS high energy proton service.

  • Glenn Flux: Speaking at the Oncology Convention

    Glenn Flux
    Royal Marsden Hospital

    The emergence and resurgence of radiotherapeutics for cancer treatment

  • Dr Tom Newsom-Davis: Speaking at the Oncology Convention

    Dr Tom Newsom-Davis
    Leaders in Oncology Care (Part of HCA healthcare UK)

    Immunotherapy and innovative systemic treatments in Oncology

  • Rob Duncombe: Speaking at the Oncology Convention

    Rob Duncombe
    The Christie NHS Foundation Trust

    Medicine Optimisation in Oncology. How to achieve best value.